Concepedia

David H. Rominger

DH

15

Publications

2.6K

Citations

15

H-Index

1991

Active since

Affiliations

Wilmington University(Current)

GlaxoSmithKline (United States)

Duke Medical Center

David H. Rominger is an author at Wilmington University specializing in transcriptional regulation, small molecules, and molecular pharmacology.

Top concepts

Publications per year

1991–2017

15

Publications

15

A G Protein-Biased Ligand at the μ-Opioid Receptor Is Potently Analgesic with Reduced Gastrointestinal and Respiratory Dysfunction Compared with Morphine

Scott M. DeWire, Dennis S. Yamashita, David H. Rominger et al. · Journal of Pharmacology and Experimental Therapeutics · 2013 · 630 citations

Quantifying Ligand Bias at Seven-Transmembrane Receptors

Sudarshan Rajagopal, Seungkirl Ahn, David H. Rominger et al. · Molecular Pharmacology · 2011 · 387 citations

Selectively Engaging β-Arrestins at the Angiotensin II Type 1 Receptor Reduces Blood Pressure and Increases Cardiac Performance

Jonathan D. Violin, Scott M. DeWire, Dennis S. Yamashita et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 362 citations

Presenilin-1 and -2 Are Molecular Targets for γ-Secretase Inhibitors

Dietmar Seiffert, Jodi D. Bradley, Cynthia M. Rominger et al. · Journal of Biological Chemistry · 2000 · 301 citations · Full text

Myelosuppression and kinase selectivity of multikinase angiogenesis inhibitors

Rakesh Kumar, M-C Crouthamel, David H. Rominger et al. · British Journal of Cancer · 2009 · 218 citations · Full text

Rows per page

1–5 of 15